Government ‘no-deal’ EU exit planning - September 2019 update

On 10 September the Government published part of its ‘no-deal’ Brexit planning documentation, including a section on drugs supplies which says:

“The reliance of medicines and medical products' supply chains on the short straits [Dover to Calais] crossing make them particularly vulnerable to severe extended delays; three-quarters of medicines come via the short straits. Supply chains are also highly regulated and require transportation that meets strict Good Distribution Practices. This can include limits on time of transit, or mean product must be transported under temperature-controlled conditions. Whilst some products can be stockpiled, others cannot due to short shelf lives - it will also not be practical to stockpile products to cover expected delays of up to six months. DHSC is developing a multi-layered approach to mitigate these risks.”

On adult social care, the document says:

“There is an assumption that there will be no major change in adult social care on the day after EU Exit. The adult social care market is already fragile due to declining financial viability of providers. An increase in inflation following EU exit would significantly impact adult social care providers due to increasing staff and supply costs, and may lead to provider failure, with smaller providers impacted within 2-3 months and larger providers 4-6 months after exit. There are also possible concurrent localised risks: transport or staff disruption, severe winter weather or flu that could exacerbate the existing market fragility, and that cumulatively could stretch resources of providers and LAs. Intelligence will continue to be gathered to forewarn of/prepare for any impacts on the sector including closure of services and handing back of contracts which are not part of normal market function.”

The document also mentions some areas which could impact on health, specifically:

  • Shortages of veterinary medicine could result outbreaks of disease in the food chain.
  • Regional disruption to roads in Kent resulting in traffic problems around London.
  • Rising electricity costs.
  • Low income groups being disproportionately affected by any price rises in food and fuel.

Londonwide LMCs’ position

Dr Michelle Drage, our Chief Executive, said of the prospect of ‘no-deal’:

“Londoners will face seeing the healthcare services which they depend on grind to a halt without a whole range of goods imported across the Channel. Supplies such as drugs are an obvious essential, but many of the other clinical and administrative supplies GP practices rely on would quickly run out in the event of a ‘no-deal’ exit from the EU. Based on the Government’s own assessments, there is the real prospect of harm to care and lives put at risk.”

“It is highly irresponsible to choose to put lives at risk in this way. It also sends a message to our European colleagues that their contributions to health and care services are not appreciated, and deters others from coming to work in London, which is a reckless course of action in the midst of a workforce crisis.”

BMA analysis

The BMA has published information for doctors on what to expect in the event of a ‘no-deal’ EU exit, covering:

  • Immigration
  • Professional qualifications.
  • Employing EEA doctors.
  • Access to medicines.
  • Access to healthcare in the UK and EU.
  • Medical research.
  • Local no deal preparations.

Read the document here.

Last updated : 07 Oct 2019

 

Latest LMC workforce survey - please complete our short survey by Friday 17 December 2021 (25 Nov 2021)

We have extended the closing date of our workforce survey to 17:00 on Friday 17 December, in recognition of the substantial time pressures on practices. Please do still take 10...
Read more »

Help us respond to the Health and Social Care Select Committee enquiry into ‘The Future of General Practice’ (25 Nov 2021)

We will be responding to this new inquiry as on behalf of London general practice and would welcome your views. We will highlight London GP teams’ commitment to patient access,...
Read more »

New Integrated Care Board CEOs (23 Nov 2021)

The five chief executive roles for London’s Integrated Care Boards (ICBs) have been appointed. They are: North West London: Rob Hurd, current North Central London ICS Joint Executive lead. North...
Read more »

Update: GP earnings declarations delayed until at least next Spring (22 Nov 2021)

Last week we were informed by the General Practitioners Committee England (GPC England) of the BMA that they had further discussions with the Department of Health and Social Care (DHSC)...
Read more »

Londonwide LMCs' Buying Group - flu vaccine offer (03 Nov 2021)

The Londonwide LMCs’ Buying Group offers discounted rates on flu vaccines via our buying group supplier MidMeds. Member practices should call Mylan (0800 358 7468), or Seqirus (08457 451 500),...
Read more »

Covid-19 guidance update – October 2021 (20 Oct 2021)

This page collates new guidance and existing guidance that has been updated since our last newsletter on 22 September. Covid-19 vaccination programme Covid-19 vaccination deployment next steps for...
Read more »

Tips of the Month October 2021 (20 Oct 2021)

We provide monthly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...
Read more »
Next Page »
« Previous Page